Synergistic integration of CRISPR/Cas and nanozymes in next-generation biosensors for ultrasensitive bacterial detection
Microchimica Acta · 2026
DOI: 10.1007/s00604-026-07905-y ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microchimica Acta, 2026. Verfasst von Fei Ren und 20 weiteren Autor:innen. Beteiligte Einrichtung: Public Health School, Mudanjiang Medical University, Mudanjiang, China. Hauptthemen laut MEDLINE: Biosensing Techniques, CRISPR-Cas Systems, Bacteria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 112 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province, Foundation for Huoju Plan Research of Mudanjiang Medical University.
Abstract (Originalsprache)
The rapid and accurate detection of pathogenic bacteria is paramount for global public health, food safety, and clinical diagnosis. While conventional methods face limitations in speed, sensitivity, and field-deployability, biosensors incorporating CRISPR/Cas systems and nanozymes have emerged as a transformative solution. This review provides a comprehensive analysis of this cutting-edge synergy. We first elucidate the fundamental mechanisms, highlighting the unparalleled programmability and specific nucleic acid cleavage activity of Class II CRISPR/Cas systems (e.g., Cas12, Cas13), and the robust, cost-effective, and tunable catalytic properties of various nanozymes (e.g., metal-based, MOF-derived). The core innovation lies in their integration: the CRISPR/Cas system acts as a highly specific molecular recognition unit, whose activation triggers the signal amplification function of nanozymes. We critically examine recent advancements in biosensing platforms that leverage this combination for the detection of diverse bacteria (e.g., Salmonella, Legionella, drug-resistant strains) via multiple readouts (colorimetric, fluorescent, electrochemical). The results demonstrate the exceptional sensitivity (often reaching attomolar or single CFU levels) and versatility achieved by these platforms. Finally, the current challenges, such as signal stability and the demand for multiplex detection, are discussed. Future development directions are also prospected, including the development of extraction-free detection methods, the fabrication of renewable sensors to achieve true point-of-care testing, and the design of novel nanozymes with higher specificity. This review not only summarizes the state-of-the-art but also charts a course for the next generation of intelligent, rapid, and accessible diagnostic tools.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Public Health School, Mudanjiang Medical University, Mudanjiang, China.
- Collaborative Research Center, Shanghai University of Medicine and Health Sciences, Shanghai, China.
- Public Health School, Mudanjiang Medical University, Mudanjiang, China. sz_rong@yeah.net.
- Public Health School, Mudanjiang Medical University, Mudanjiang, China. mahongkunmdjmu@163.com.
- Nursing School, Mudanjiang Medical University, Mudanjiang, China. zoulinamdj@163.com.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
- Foundation for Huoju Plan Research of Mudanjiang Medical University
- Foundation for Special Program of Supervisor Scientific Research of Mudanjiang Medical University
- The Fundamental Research Funds for the Universities of Heilongjiang Province
- Youth the Science and Technology Talents Team Project of Chunyan Plan of Heilongjiang Province
Zitieren
APA
Ren, F., Liu, D., Ren, H., Zhang, H., Zhang, P., Lin, H., Li, C., Dong, J., An, S., Ge, X., Cheng, L., Yang, F., Liu, J., Fu, J., Tang, F., Wang, F., Liu, T., Pan, H., Rong, S., …, & Zou, L. (2026). Synergistic integration of CRISPR/Cas and nanozymes in next-generation biosensors for ultrasensitive bacterial detection. Microchimica Acta. https://doi.org/10.1007/s00604-026-07905-y
Vancouver
Ren F, Liu D, Ren H, Zhang H, Zhang P, Lin H, et al. Synergistic integration of CRISPR/Cas and nanozymes in next-generation biosensors for ultrasensitive bacterial detection. Microchimica Acta. 2026. doi:10.1007/s00604-026-07905-y
BibTeX
@article{Ren2026,
author = {Ren, Fei and Liu, Dongxue and Ren, Huanyu and Zhang, Hui and Zhang, Ping and Lin, Hongkun and Li, Chen and Dong, Jing and An, Shanshan and Ge, Xiuhong and Cheng, Lang and Yang, Feiyan and Liu, Jiahan and Fu, Jiabo and Tang, Furui and Wang, Feifei and Liu, Tianzi and Pan, Hongzhi and Rong, Shengzhong and Ma, Hongkun and Zou, Lina},
title = {Synergistic integration of CRISPR/Cas and nanozymes in next-generation biosensors for ultrasensitive bacterial detection},
journal = {Microchimica Acta},
year = {2026},
doi = {10.1007/s00604-026-07905-y}
}
EUVIMED